2026 Global: Indwelling Pleural Catheters Market -Competitive Review (2032) report
Description
The 2026 Global: Indwelling Pleural Catheters Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Becton, Dickinson and Company (BD) is a leading global medical technology firm that underpins IPC practice through its PleurX indwelling catheter system and numerous drainage accessories. Headquarters: Franklin Lakes, New Jersey, United States. Teleflex Incorporated markets thoracic drainage catheters under the Portex brand and provides IPC‑compatible components that integrate with outpatient drainage workflows. Headquarters: Wayne, Pennsylvania, United States. Atrium Medical Corporation has historically supplied pleural access devices and catheter components that have supported IPC implementation in hospital settings. Headquarters: Hudson, New Hampshire, United States. Getinge AB offers a broad portfolio of thoracic care devices and service solutions that support IPC programs from inpatient wards to home‑care settings. Headquarters: Getinge, Sweden. Collectively, these firms influence product standardization, clinician training, and supply‑chain resilience essential to IPC adoption and long‑term management. Each firm maintains global manufacturing, regulatory, and distribution capabilities that enable rapid IPC technology diffusion in emerging markets and support ongoing clinical research in pleural disease.
Coloplast A/S is headquartered in Humlebæk, Denmark, and provides implantable ports and thoracic drainage components that complement pleural‑catheter programs, with distribution networks spanning Europe, North America, and Asia. ConvaTec Group plc is headquartered in Reading, United Kingdom, and offers vascular‑access solutions alongside wound and ostomy care products that intersect with IPC care pathways, including patient‑support services. Terumo Corporation is headquartered in Tokyo, Japan, and supplies a broad family of catheter technologies and disposables used in pleural drainage workflows and patient monitoring. Nipro Corporation is headquartered in Osaka, Japan, and supplies central and peripheral catheter products and drainage systems deployed in pleural space management, with a multinational footprint. Together, these brands provide interoperability across drainage kits, connectors, and monitoring systems that facilitate standardized IPC protocols and cross‑border clinical collaborations.
AngioDynamics, headquartered in Latham, New York, United States, focuses on interventional therapies and catheter‑based devices that underpin drainage and access applications relevant to IPC care. Boston Scientific Corporation is headquartered in Marlborough, Massachusetts, United States, and supplies a range of vascular and interventional catheters and support products used in pleural drainage programs and adjacent imaging workflows.
Becton, Dickinson and Company (BD) is a leading global medical technology firm that underpins IPC practice through its PleurX indwelling catheter system and numerous drainage accessories. Headquarters: Franklin Lakes, New Jersey, United States. Teleflex Incorporated markets thoracic drainage catheters under the Portex brand and provides IPC‑compatible components that integrate with outpatient drainage workflows. Headquarters: Wayne, Pennsylvania, United States. Atrium Medical Corporation has historically supplied pleural access devices and catheter components that have supported IPC implementation in hospital settings. Headquarters: Hudson, New Hampshire, United States. Getinge AB offers a broad portfolio of thoracic care devices and service solutions that support IPC programs from inpatient wards to home‑care settings. Headquarters: Getinge, Sweden. Collectively, these firms influence product standardization, clinician training, and supply‑chain resilience essential to IPC adoption and long‑term management. Each firm maintains global manufacturing, regulatory, and distribution capabilities that enable rapid IPC technology diffusion in emerging markets and support ongoing clinical research in pleural disease.
Coloplast A/S is headquartered in Humlebæk, Denmark, and provides implantable ports and thoracic drainage components that complement pleural‑catheter programs, with distribution networks spanning Europe, North America, and Asia. ConvaTec Group plc is headquartered in Reading, United Kingdom, and offers vascular‑access solutions alongside wound and ostomy care products that intersect with IPC care pathways, including patient‑support services. Terumo Corporation is headquartered in Tokyo, Japan, and supplies a broad family of catheter technologies and disposables used in pleural drainage workflows and patient monitoring. Nipro Corporation is headquartered in Osaka, Japan, and supplies central and peripheral catheter products and drainage systems deployed in pleural space management, with a multinational footprint. Together, these brands provide interoperability across drainage kits, connectors, and monitoring systems that facilitate standardized IPC protocols and cross‑border clinical collaborations.
AngioDynamics, headquartered in Latham, New York, United States, focuses on interventional therapies and catheter‑based devices that underpin drainage and access applications relevant to IPC care. Boston Scientific Corporation is headquartered in Marlborough, Massachusetts, United States, and supplies a range of vascular and interventional catheters and support products used in pleural drainage programs and adjacent imaging workflows.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
